Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3667

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3667). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium, displaying detailed molecular arrangement including calcium ion complexation and hydration, consistent with the active ingredient atorvastatin calcium.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line chart showing cumulative incidence percentages over approximately 3.5 years, comparing Atorvastatin to placebo. The chart tracks the increase in incidence, with Atorvastatin exhibiting a lower cumulative incidence than placebo. A hazard ratio (HR) with confidence interval and p-value is also displayed, indicating statistical comparison between the two groups.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line chart depicting cumulative hazard percentage over a 5-year period comparing placebo and atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up, while the y-axis shows cumulative hazard percentage. Two lines show atorvastatin consistently lower than placebo, indicating a hazard ratio (HR) of 0.63 with a p-value of 0.001.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A Kaplan-Meier curve graph comparing the time to first major cardiovascular endpoint over 5 years for atorvastatin 10 mg and 80 mg doses. The y-axis shows the percentage of subjects experiencing the event, and the x-axis shows time in years. The graph includes a hazard ratio (HR 0.78) with confidence interval and p-value (0.0002), illustrating differences in event rates between the two dosages.*

FDA Label Image

Atorvastatinfigure5. (Atorvastatinfigure5)

Label for Atorvastatin Calcium Tablets, USP 10 mg by Camber Pharmaceuticals, showing 90 tablets in the package. The label includes storage instructions, contact information, barcode, and manufacturing details, with a pink unvarnished area on the right side.*

FDA Label Image

Atorvastatinfigure6. (Atorvastatinfigure6)

Label for Atorvastatin Calcium Tablets, USP 20 mg, a film-coated oral tablet. The label indicates a package of 90 tablets and states Rx only. Manufacturer details include Camber Pharmaceuticals, Inc. and Annora Pharma Pvt. Ltd. Storage instructions and contact information are also visible. The label contains a barcode and a pink area marked as unvarnished.*

FDA Label Image

Atorvastatinfigure7. (Atorvastatinfigure7)

Label for Atorvastatin Calcium Tablets USP 40 mg, film-coated oral tablets. The label includes the NDC 31722-426-90, manufacturer Camber Pharmaceuticals, Inc., Piscataway, NJ, and indicates packaging of 90 tablets. It also mentions manufacturing by Annora Pharma Pvt. Ltd., India, along with storage and dispensing instructions and a barcode.*

FDA Label Image

Atorvastatinfigure8. (Atorvastatinfigure8)

Label for Atorvastatin Calcium Tablets USP 80 mg by Camber Pharmaceuticals, Inc. The package contains 90 film-coated tablets. The label includes storage instructions, contact information, and manufacturer details for Annora Pharma Pvt. Ltd. The label features a pink unvarnished area and a barcode.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.